Cetuximab Plus Irinotecan Increases PFS In Metastatic Colorectal Cancer, EPIC Finds
Socio-Economic Factors, Access To Care, Associated With More Aggressive Cancers
Darbepoetin Didn’t Decrease Blood Transfusions, Lowered Overall Survival, Study Finds
GSK HPV Vaccine Offers Protection From 4 HPV Types
Aspirin Use Associated With Lower Cancer Indicence, Death
Early ADT Doesn’t Offer Survival Advantage—ASCO
Gleevec Decreases Recurrence Of Gastrointestinal Tumor
NCI-Approved Cancer Center, Cooperative Group Trials
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - As more people are surviving cancer, we must continue funding bold science









